Teladoc Company Insiders

TDOC Stock  USD 7.27  0.34  4.91%   
About 80 percent of Teladoc's insiders are selling. The analysis of the overall insider sentiment regarding Teladoc suggests that quite a large number of insiders are terrified. Teladoc employs about 4.6 K people. The company is managed by 49 executives with a total tenure of roughly 185 years, averaging almost 3.0 years of service per executive, having 94.29 employees per reported executive.
Jason Gorevic  CEO
Chief Executive Officer, Director
David Snow  Chairman
Independent Chairman of the Board

Insider Sentiment 20

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-06-03Fernando M. RodriguesDisposed 4174 @ 6.91View
2025-06-02Fernando M RodriguesDisposed 2358 @ 6.86View
2025-03-20Adam C VandervoortDisposed 11011 @ 8.42View
2024-12-02Carlos NuenoDisposed 2389 @ 11.93View
2024-09-12Thomas MckinleyAcquired 4000 @ 7.69View
2024-09-03Nikolaos P NanisDisposed 1033 @ 7.16View
2024-08-07Stephany VerstraeteDisposed 15000 @ 7.6View
2024-08-06Thomas MckinleyAcquired 7000 @ 7.57View
2024-08-05Vidya Raman-TangellaDisposed 1537 @ 7.33View
2024-08-02Michael Willem WatersDisposed 6053 @ 8.14View
Monitoring Teladoc's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.

Teladoc's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Teladoc's future performance. Based on our forecasts, it is anticipated that Teladoc will maintain a workforce of about 4620 employees by July 2025.
 
Yuan Drop
 
Covid

Teladoc Management Team Effectiveness

The company has return on total asset (ROA) of (0.0301) % which means that it has lost $0.0301 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5449) %, meaning that it created substantial loss on money invested by shareholders. Teladoc's management efficiency ratios could be used to measure how well Teladoc manages its routine affairs as well as how well it operates its assets and liabilities. As of June 7, 2025, Return On Tangible Assets is expected to decline to -0.58. The current year's Return On Capital Employed is expected to grow to -0.38. At present, Teladoc's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 58.6 M, whereas Non Current Assets Total are forecasted to decline to about 1.8 B.
As of June 7, 2025, Common Stock Shares Outstanding is expected to decline to about 96.7 M. The current year's Net Loss is expected to grow to about (11.7 B)

Teladoc Workforce Comparison

Teladoc is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 72,272. Teladoc holds roughly 4,620 in number of employees claiming about 6% of equities under Health Care industry.

Teladoc Profit Margins

The company has Profit Margin (PM) of (0.4) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.780.7076
Significantly Up
Slightly volatile

Teladoc Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Teladoc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Teladoc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Teladoc insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-06-01
1.0357
29
28
 375,292 
 185,705 
2025-03-01
0.8438
27
32
 1,260,426 
 218,438 
2024-12-01
0.7083
17
24
 85,579 
 103,546 
2024-09-01
0.7273
40
55
 127,618 
 193,592 
2024-06-01
0.8
52
65
 811,123 
 248,280 
2024-03-01
1.0854
89
82
 1,498,223 
 614,438 
2023-12-01
0.5
22
44
 156,709 
 314,805 
2023-09-01
0.4865
18
37
 96,728 
 151,011 
2023-06-01
0.8333
30
36
 214,598 
 164,234 
2023-03-01
0.9583
69
72
 897,076 
 225,130 
2022-12-01
0.4
4
10
 244,314 
 9,640 
2022-09-01
0.3333
2
6
 136,434 
 7,919 
2022-06-01
2.3333
28
12
 860,659 
 26,560 
2022-03-01
1.0513
41
39
 315,714 
 112,941 
2021-12-01
0.4
8
20
 9,368 
 38,251 
2021-09-01
0.35
7
20
 29,064 
 72,067 
2021-06-01
0.5273
29
55
 464,708 
 832,453 
2021-03-01
0.6917
83
120
 1,230,777 
 2,843,245 
2020-12-01
0.5067
38
75
 491,805 
 1,266,394 
2020-09-01
0.561
46
82
 186,653 
 363,614 
2020-06-01
0.6055
66
109
 431,627 
 871,658 
2020-03-01
0.7377
45
61
 329,920 
 218,254 
2019-12-01
0.7188
23
32
 75,971 
 158,777 
2019-09-01
0.4865
18
37
 65,556 
 203,537 
2019-06-01
0.8864
39
44
 196,677 
 396,337 
2019-03-01
0.7544
43
57
 388,065 
 400,787 
2018-12-01
0.7414
43
58
 287,554 
 505,705 
2018-09-01
0.6154
32
52
 227,415 
 549,196 
2018-06-01
1.3714
48
35
 212,563 
 332,155 
2018-03-01
0.78
39
50
 952,706 
 1,111,039 
2017-12-01
0.7692
10
13
 455,809 
 382,753 
2017-09-01
0.5556
5
9
 72,645 
 314,756 
2017-06-01
1.6471
28
17
 236,083 
 4,274,082 
2017-03-01
1.3333
8
6
 1,190,343 
 360,900 
2016-12-01
0.1538
2
13
 36,320 
 546,497 
2016-09-01
1.6667
20
12
 290,338 
 1,485,730 
2016-06-01
3.6667
11
3
 115,308 
 20,000 
2016-03-01
18.0
18
1
 952,216 
 15,000 
2015-09-01
1.2692
33
26
 18,119,251 
 27,795,600 

Teladoc Notable Stakeholders

A Teladoc stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Teladoc often face trade-offs trying to please all of them. Teladoc's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Teladoc's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
MD EECoFounderProfile
CPA IIICEO DirectorProfile
Jason GorevicChief Executive Officer, DirectorProfile
David SnowIndependent Chairman of the BoardProfile
Andrew TuritzSenior Vice President of Corporate DevelopmentProfile
Alon MatasPresident BetterHelpProfile
Kelly BlissPresident HealthProfile
Fernando MadeiraPresident BetterHelpProfile
Andy PuterbaughPresident SystemsProfile
Gabriel CappucciSenior Vice President Chief Accounting Officer, ControllerProfile
Laizer KornwasserPresident MarketsProfile
Carlos NuenoPresident InternationalProfile
Mala MurthyChief Financial OfficerProfile
David SidesChief Operating OfficerProfile
Christopher BischoffIndependent DirectorProfile
David ShedlarzIndependent DirectorProfile
William FristIndependent DirectorProfile
Mark SmithIndependent DirectorProfile
Kenneth PaulusIndependent DirectorProfile
Peter McClennenIndependent DirectorProfile
Sandra FenwickIndependent DirectorProfile
Thomas McKinleyIndependent DirectorProfile
Karen DanielIndependent DirectorProfile
Mike WatersChief OfficerProfile
Chris StenrudChief OfficerProfile
Catherine JacobsonIndependent DirectorProfile
Stella SanchezChief MarketingProfile
Michelle BucariaChief Human Resource OfficerProfile
Nikolaos NanisChief OfficerProfile
Lewis LevyChief Medical OfficerProfile
Vidya RamanTangellaChief OfficerProfile
Yulun WangHead of Research and DevelopmentProfile
Stephanie VerstraeteChief Marketing OfficerProfile
Hemant TanejaDirectorProfile
Glen TullmanDirectorProfile
Courtney McLeodDirector CommunicationProfile
Michael WatersChief OfficerProfile
Joseph CpaSenior OfficerProfile
Richard NapolitanoSenior Vice President Chief Accounting OfficerProfile
Claus JensenChief OfficerProfile
Daniel TrencherSenior Vice President - Corporate StrategyProfile
Adam VandervoortChief Legal Officer and SecretaryProfile
Arnnon GeshuriChief Human Resource OfficerProfile
Adam JDChief SecretaryProfile
Stephany VerstraeteChief OfficerProfile
Michael MinchakVice RelationsProfile
George BrooksCoFounderProfile
Jamila TaylorChief OfficerProfile
CPA CFAVice RelationsProfile

About Teladoc Management Performance

The success or failure of an entity such as Teladoc often depends on how effective the management is. Teladoc management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Teladoc management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Teladoc management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.56)(0.58)
Return On Capital Employed(0.40)(0.38)
Return On Assets(0.28)(0.30)
Return On Equity(0.67)(0.71)
Please note, the presentation of Teladoc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teladoc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teladoc's management manipulating its earnings.

Teladoc Workforce Analysis

Traditionally, organizations such as Teladoc use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Teladoc within its industry.

Teladoc Manpower Efficiency

Return on Teladoc Manpower

Revenue Per Employee556.2K
Revenue Per Executive52.4M
Net Loss Per Employee216.7K
Net Loss Per Executive20.4M
Working Capital Per Employee156.4K
Working Capital Per Executive14.7M

Complementary Tools for Teladoc Stock analysis

When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account